AirXpanders Inc., a company developing technology to address current

unmet needs for patients who require tissue expansion for breast

reconstruction surgery, today announced that it has expanded its

senior management team with new hires to help the company prepare for

a successful launch of AeroForm in early 2013.

"We are honored to attract such exceptionally talented, experienced,

and successful professionals to AirXpanders to complement our growing

leadership team as we prepare for a potential U.S. launch of AeroForm

early next year," says Scott Dodson, President and CEO of AirXpanders.

"Enrollment in the pivotal XPAND study of our AeroForm tissue

expansion device in mastectomy patients going through breast

reconstruction is on track. As the study continues, we are working

diligently to prepare our regulatory submission to the FDA and ensure

that we have the proper quality systems in place for a successful

commercial rollout. These high caliber team members will play a

crucial part in the growth and expansion of our company and will add

to our commitment to quality and excellence."

Naghmeh Nouri has been named Senior Director of Quality and

Regulatory, John Lai joins the company as Director of Finance, and

Tony Morefield joins AirXpanders as Senior Director of Operations.

Nouri joins AirXpanders with 28 years of experience as a scientist and

quality expert. She was previously VP of Quality and Regulatory at

Asante Solutions and VP of Quality and Regulatory at Health Hero

Network where she led all activities for quality and regulatory

implementation, product maintenance, and secured a CE Mark, 510K and

managed a new series of FDA regulations. Nouri holds both an M.S. and

a B.S. from the Rutgers Electrical Engineering Honors Program.

Lai, a seasoned financial services professional, joins AirXpanders

after 14 years of experience in the field of accounting and finance.

Previously, John served as Director of Accounting and Finance Services

for Montgomery Professional Services and is an expert in financial

services for medical device companies. John holds a B.A. in Accounting

from Seattle University.

Morefield has over 15 years of experience in the medical device and

aerospace industry with a focus on transitioning innovative

technologies through late stage development into full scale

manufacturing. He most recently held the position of Senior Director

of Manufacturing and Engineering at Avantis Medical Systems where he

was responsible for ramping operations during the course of clinical

studies and into full commercialization with the eventual transition

into off-shore manufacturing. Morefield holds a B.S. from the

University of Oregon.

About AirXpanders

AirXpanders Inc.


is a tissue-expansion company focused on the area of breast cancer

reconstruction. By employing a revolutionary patient-controlled

expander, activated by a wireless remote control, the often painful

process of recovering one's feminine shape after cancer can

potentially be eased with this needle-free technology that is easy to

use and may enable the patient to proceed to a permanent implant much

faster than the current standard-of-care. At this time, AirXpanders'

products are not cleared or approved for sale. AirXpanders is backed

by Vivo Ventures, GBS Venture Partners, Prolog Ventures, Heron Capital

and Shalon Ventures.